Portal hypertension and the outcome of surgery for hepatocellular carcinoma in compensated cirrhosis: A systematic review and meta-analysis

Reply to Letter

(2015) Matteo Cescon et al.   ANNALS OF SURGERY

Value of Transient Elastography Measured With Fibroscan in Predicting the Outcome of Hepatic Resection for Hepatocellular Carcinoma

(2015) Annalisa Berzigotti et al.   ANNALS OF SURGERY

EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma

(2015) et al.   JOURNAL OF HEPATOLOGY

Hepatocellular carcinoma: clinical frontiers and perspectives

(2014) Jordi Bruix et al.   GUT

Liver cirrhosis

(2014) Emmanuel A Tsochatzis et al.   LANCET

Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement

(2013) David Moher   ANNALS OF INTERNAL MEDICINE

Assessing Bias in Studies of Prognostic Factors

(2013) Jill A. Hayden et al.   ANNALS OF INTERNAL MEDICINE

Hepatocellular carcinoma: ESMO-ESDO Clinical Practice Guidelines for diagnosis, treatment and follow-up

(2012) C. Verslype et al.   ANNALS OF ONCOLOGY

Value of Transient Elastography Measured With Fibroscan in Predicting the Outcome of Hepatic Resection for Hepatocellular Carcinoma

(2012) Matteo Cescon et al.   ANNALS OF SURGERY

Hepatic venous pressure gradient in the assessment of portal hypertension before liver resection in patients with cirrhosis

(2012) E. Boleslawski et al.   BRITISH JOURNAL OF SURGERY

Intraoperative portal venous pressure and long-term outcome after curative resection for hepatocellular carcinoma

(2012) M. Hidaka et al.   BRITISH JOURNAL OF SURGERY

Chemoembolization With Doxorubicin-Eluting Beads for Unresectable Hepatocellular Carcinoma: Five-Year Survival Analysis

(2012) Katerina Malagari et al.   CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY

Elastography, Spleen Size, and Platelet Count Identify Portal Hypertension in Patients With Compensated Cirrhosis

(2012) Annalisa Berzigotti et al.   GASTROENTEROLOGY

Survival of patients with hepatocellular carcinoma treated by transarterial chemoembolisation (TACE) using Drug Eluting Beads. Implications for clinical practice and trial design

(2012) Marta Burrel et al.   JOURNAL OF HEPATOLOGY

Hepatocellular carcinoma

(2012) Alejandro Forner et al.   LANCET

Hepatic resection for hepatocellular carcinoma in patients with Child–Pugh's A cirrhosis: is clinical evidence of portal hypertension a contraindication?

(2012) Roberto Santambrogio et al.   HPB

Management of hepatocellular carcinoma: An update

(2011) Jordi Bruix et al.   HEPATOLOGY

Assessment of portal hypertension by transient elastography in patients with compensated cirrhosis and potentially resectable liver tumors

(2011) Elba Llop et al.   JOURNAL OF HEPATOLOGY

Hepatocellular carcinoma in cirrhotic patients with portal hypertension: Is liver resection always contraindicated?

(2011) Andrea Ruzzenente   WORLD JOURNAL OF GASTROENTEROLOGY

Is Portal Hypertension a Contraindication to Hepatic Resection?

(2009) Alessandro Cucchetti et al.   ANNALS OF SURGERY

The use of β-adrenergic drugs improves hepatic oxygen metabolism in cirrhotic patients undergoing liver resection

(2009) Pilar Taurà et al.   JOURNAL OF HEPATOLOGY

The clinical use of HVPG measurements in chronic liver disease

(2009) Jaime Bosch et al.   Nature Reviews Gastroenterology & Hepatology

Noninvasive Prediction of Clinically Significant Portal Hypertension and Esophageal Varices in Patients With Compensated Liver Cirrhosis

(2008) Annalisa Berzigotti et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Neither Multiple Tumors Nor Portal Hypertension Are Surgical Contraindications for Hepatocellular Carcinoma

(2008) Takeaki Ishizawa et al.   GASTROENTEROLOGY

East meets the West—portal pressure predicts outcome of surgical resection for hepatocellular carcinoma

(2008) Alejandro Forner et al.   Nature clinical practice. Gastroenterology & hepatology